Translational development phase in personalised medicine a focus group on in silico preclinical models
June 11, 2021

Shortly after the successful focus group to explore the industry perspective on preclinical research, the second working session on June 1st assessing the translational development phase looked at in silico models for personalised medicine. During this second meeting, the group, composed of five experts from the field, explored some common bottlenecks and potential solutions. The importance of high-quality data collection and sharing was debated, as well as the relevance of model validation for ensuring reliable results and regulation-related issues.

Read more
How many patients does it take to build a robust stratification cohort?
March 30, 2021

No generic approach for sample size estimation can be made in personalised medicine when designing a stratification cohort. The conclusion is drawn from the first stakeholder consultation by the PERMIT project which looked to identify approaches to estimate the number of patients needed to be included in a cohort for different types of stratification studies using machine learning.

Read more
2nd PERMIT General Assembly
January 18, 2021

The PERMIT Project held its second General Assembly meeting on the 15th of January 2021. All consortium members gathered to share the milestones and achievements of the first year, focusing on the outcomes of the scoping review of PM methodologies. During the meeting, the work plan for 2021 was also presented and discussed.

Read more
PERMIT project holds Gap Analysis Workshop
December 11, 2020

On December 1 and 2, 2020 the PERMIT project held its Gap Analysis Workshop. This important milestone of the project corresponds to the final phase of the scoping review process that was carried out in the first year of the project, under the lead of the Mario Negri Institute for Pharmacological Research. Representatives from all consortium members participated in the workshop, as well as representatives of the EMA, EUnetHTA and the CTFG, who are associated partners of the PERMIT project.

Read more
PERMIT Industry Survey
October 27, 2020

PERMIT has launched a brief survey to to map patient stratification strategies currently undertaken by industry. It will contribute to a better understanding of the challenges and opportunities in the translational development phase of personalised medicine clinical trials

Read more
PERMIT Kick-Off Meeting
February 11, 2020

The official kick-off meeting of the PERMIT project took place on Friday, January 24th in Paris, France. All consortium participants and partners attended, and actively participated in discussions on all seven project work packages. 

Read more